Clinical trials: Female Pattern Baldness
Androgenetic Alopecia, Androgenic Alopecia
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
To demonstrate that the ALRV5XR multi-molecular targeting treatment regimen of a daily shampoo, conditioner, topical serum and oral supplement is superior to placebo in promoting hair growth as assessed by change in hair density…
- Conditions
- Androgenetic Alopecia, Androgenic Alopecia, Telogen Effluvium, Thinning Hair
- Trial name
- REBOOT-WOMEN (NCT04450602)
- Testing
- ALRV5XR, ALRV5XR Conditioner, ALRV5XR Hair Follicle Serum (Nutriment)
- Where
- United States
- Volunteers
- 46 people
- Sponsor
- Arbor Life Labs
Androgenetic Alopecia, Female Pattern Hair Loss
Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
The purpose of this study is to determine in women the risk/benefit profile and non-inferiority of a topical 5% Minoxidil foam formulation applied once daily for the treatment of androgenetic alopecia in comparison to 2% MTS used…
- Trial name
- NCT00958750
- Testing
- minoxidil
- Where
- Germany
- Volunteers
- 113 people
- Sponsor
- Charite University, Berlin, Germany
Early Female Pattern Hair Loss (FPHL)
Efficacy and Safety Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human Volunteers
The purpose of this clinical trial is to evaluate the efficacy and safety of Olistic Next Women, a nutraceutical supplement, in women diagnosed with early FPHL.This 6-month, open-label, interventional clinical trial investigates…
- Trial name
- NCT07300228
- Testing
- Drinkable multifactorial food supplement containing vitamins, minerals, amino acids, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women +50.
- Where
- Spain
- Volunteers
- 39 people
- Sponsor
- Olistic Research Labs S.L.
Androgenic Alopecia
Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia
Androgenetic alopecia is a common form of hair loss that can affect quality of life. This randomized controlled trial aims to evaluate the efficacy and safety of topical 2-Deoxy-D-ribose (2dDR) hydrogel compared with topical…
- Trial name
- NCT07502976
- Testing
- Topical 2-Deoxy-D-ribose Hydrogel, Topical Minoxidil 5% Solution
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- Kasr El Aini Hospital
Androgenetic Alopecia
Topical Cetirizine in Androgenetic Alopecia in Females
Cetirizine is a safe and selective, second-generation histamine H1 receptor antagonist, widely used in daily practice. A study showed that cetirizine causes a significant reduction in both the inflammatory cell infiltrate and…
- Trial name
- NCT04481412
- Testing
- Topical cetirizine, Topical minoxidil
- Where
- Egypt
- Volunteers
- 66 people
- Sponsor
- Cairo University
Androgenetic Alopecia (AGA)
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Androgenetic Alopecia (AGA) in female adults.
- Trial name
- NCT07012486
- Testing
- Oral DHA + Topical minoxidil 5%, Topical Minoxidil 5%
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Shanghai Zhongshan Hospital